1146415-33-9

Basic information

• Product Name: 2-methyl-1,3'-bipyrrolidine hydrochloride
• Synonyms: 2-methyl-1,3'-bipyrrolidine hydrochloride;2-Methyl-1,3'-bipyrrolidine dihydrochloride;1,3'-Bipyrrolidine, 2-Methyl-, dihydrochloride
• CAS NO: 1146415-33-9
• Molecular Formula: C9H18N2.2(HCl)
• Molecular Weight: 190.71356
• Mol File: 1146415-33-9.mol
• Article Data: 12

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-methyl-1,3'-bipyrrolidine hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: 2-methyl-1,3'-bipyrrolidine hydrochloride(1146415-33-9)
• EPA Substance Registry System: 2-methyl-1,3'-bipyrrolidine hydrochloride(1146415-33-9)

Safety Data

• Hazardous Substances Data: 1146415-33-9(Hazardous Substances Data)

Upstream product

• 1146415-56-6 2-(2R)-methyl-[1,3'(3'R)]bipyrrolidinyl-1'-carboxylic acid tert-butyl ester 
• 1146415-53-3 2-(2S)-methyl-[1,3'(3'R)]bipyrrolidinyl-1'-carboxylic acid tert-butyl ester 
• 1146415-50-0 2-(2R)-methyl-[1,3'(3'S)]bipyrrolidinyl-1'-carboxylic acid tert-butyl ester 
• 1146415-49-7 2-(2S)-methyl-[1,3'(3'S)]bipyrrolidinyl-1'-carboxylic acid tert-butyl ester 
• 101385-93-7 3-oxo-pyrrolidine-1-carboxylic acid tert-butyl ester 
• 765-38-8 (R)-(-)-2-methylpyrrolidine 
• 1146415-31-7 2-methyl-[1,3']bipyrrolidinyl-1'-carboxylic acid tert-butyl ester 

Downstream Products

• 1228673-76-4 2-[2-methyl-4-((2S,3'S)-2-methyl-[1,3']bipyrrolidinyl-1'-yl)-phenyl]-8-oxa-2-aza-spiro[4.5]decan-1-one 
• 1228674-03-0 2-[2-methyl-4-((2R,3'S)-2-methyl-[1,3']bipyrrolidinyl-1'-yl)-phenyl]-9-oxa-2-aza-spiro[5.5]undecan-1-one 
• 1228602-74-1 2-[2-methyl-4-((2R,3'S)-2-methyl-[1,3']bipyrrolidinyl-1'-yl)-phenyl]-1-oxo-2,8-diaza-spiro[4.5]decane-8-carboxylic acid tert-butyl ester 
• 1146699-80-0 (2R,3'S)-5-fluoro-2-methyl-N-[2-methyl-4-(2-methyl[1,3']bipyrrolidinyl-1'-yl) phenyl]benzamide 
• 1146699-86-6 (2S,3'S)-5-fluoro-2-methyl-N-[2-methyl-4-(2-methyl[1,3']bipyrrolidinyl-1'-yl) phenyl]benzamide 
• 1146852-39-2 (2R,3'R)-5-fluoro-2-methyl-N-[2-methyl-4-(2-methyl[1,3']bipyrrolidinyl-1'-yl) phenyl]benzamide 
• 1350411-29-8 2-methyl-4-((2S,3′S)-2-methyl[1,3′]bipyrrolidinyl-1′-yl)-N-(tetrahydropyran-4-yl)benzamide 
• 1350411-30-1 2-methyl-4-((2S,3'S)-2-methyl[1,3']bipyrrolidinyl-1'-yl)-N-(tetrahydropyran-4-yl)benzamide 
• 1350411-35-6 N-(1-cyclopentylmethylpiperidin-4-yl)-2-[4-((2S,3'S)-2-methyl[1,3']bipyrrolidinyl-1'-yl)phenyl]acetamide 
• 1350411-34-5 4-[2-[4-((2S,3'S)-2-methyl[1,3']bipyrrolidinyl-1'-yl)phenyl]acetylamino]piperidine-1-carboxylic acid ethyl ester 
• 1350411-33-4 2-[4-((2S,3'S)-2-methyl[1,3']bipyrrolidinyl-1'-yl)phenyl]-N-piperidin-4-yl-acetamide hydrochloride 

Relevant articles and documents

Synthesis, characterization, and biological assessment of the four stereoisomers of the H3 receptor antagonist 5-fluoro-2-methyl-N-[2- methyl-4-(2-methyl[1,3′]bipyrrolidinyl-1′-yl)phenyl]benzamide

This Letter describes the asymmetric synthesis of the four stereoisomers (8a-8d) of a potent and highly selective histamine H3 receptor (H3R) antagonist, 5-fluoro-2-methyl-N-[2-methyl-4-(2-methyl[1, 3′]bipyrrolidinyl-1′-yl) phenyl]be

SUBSTITUTED N-PHENYL SPIROLACTAM BIPYRROLIDINES, PREPARATION AND THERAPEUTIC USE THEREOF

The present invention discloses and claims a series of substituted N-phenyl spirolactam bipyrrolidines of formula (I). (Formula (I)) Wherein R1, R2, R3, R4, m, n, p and s are as described herein. More specifical

SUBSTITUTED N-HETEROARYL BIPYRROLIDINE CARBOXAMIDES, PREPARATION AND THERAPEUTIC USE THEREOF

The present invention discloses and claims a series of substituted N-heteroaryl bipyrrolidine carboxamides of formula (I). Wherein R1 R2, R3, R4, Q1, Q2, Q3, Q4, X, m